Valuation Lundbeck Nasdaq Copenhagen

Stocks

Market Closed - Nasdaq Copenhagen 11:20:00 2026-10-09 EDT			5-day change	1st Jan Change
43.80 ^DKK	-0.11%		+5.04%	+20.99%

09-25	H. Lundbeck A/S Relocates Its Us Headquarters from Deerfield, Illinois, to Greater Boston, Massachusetts	CI
09-25	Danish Biopharma Group H. Lundbeck to Relocate US Headquarters to Greater Boston	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	25,433	31,719	39,416	41,398	45,127	-	-
Change	-	24.72%	24.27%	5.03%	9.01%	-	-
Enterprise Value (EV) ¹	27,464	31,008	51,598	49,619	49,130	44,946	41,174
Change	-	12.91%	66.4%	-3.84%	-0.98%	-8.52%	-8.39%
P/E	13.5x	14.2x	13x	13.4x	10.2x	9.93x	10.5x
PBR	1.24x	1.47x	1.64x	1.72x	1.6x	1.44x	1.31x
PEG	-	0.7x	0.3x	8.5x	0.3x	4.1x	-1.98x
Capitalization / Revenue	1.39x	1.59x	1.79x	1.68x	1.75x	1.73x	1.77x
EV / Revenue	1.51x	1.56x	2.34x	2.01x	1.9x	1.72x	1.61x
EV / EBITDA	5.89x	5.49x	8.13x	6.3x	6.02x	5.43x	5.29x
EV / EBIT	9.63x	9.71x	15.8x	9.41x	8.03x	7.2x	7x
EV / FCF	10.2x	8.66x	18.7x	10.2x	8.38x	7.4x	7.37x
FCF Yield	9.83%	11.5%	5.35%	9.8%	11.9%	13.5%	13.6%
Dividend per Share ²	0.58	0.7	0.95	1.15	1.552	1.398	1.517
Rate of return	2.23%	2.14%	2.3%	2.66%	3.38%	3.04%	3.3%
EPS ²	1.93	2.31	3.17	3.22	4.519	4.628	4.383
Distribution rate	30.1%	30.3%	30%	35.7%	34.3%	30.2%	34.6%
Net sales ¹	18,246	19,912	22,004	24,630	25,860	26,092	25,496
EBITDA ¹	4,663	5,652	6,347	7,881	8,156	8,271	7,789
EBIT ¹	2,852	3,195	3,270	5,275	6,117	6,243	5,883
Net income ¹	1,916	2,290	3,143	3,192	4,567	4,619	4,293
Net Debt ¹	2,031	-711	12,182	8,221	4,003	-181.8	-3,953
Reference price ²	26.05	32.76	41.32	43.16	45.96	45.96	45.96
Nbr of stocks (in thousands)	992,840	992,840	992,011	991,227	991,227	-	-
Announcement Date	2/7/23	2/7/24	2/5/25	2/4/26	-	-	-

¹DKK in Million²DKK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	33.55x	12.18x	25.21x	0.58%	1,051B
JOHNSON & JOHNSON	29.08x	6.43x	18.37x	2.04%	630B
ABBVIE INC.	35.19x	8.13x	16.76x	2.51%	489B
MERCK & CO., INC.	105.8x	5.93x	25.27x	2.34%	359B
ROCHE HOLDING AG	19.31x	4.72x	11.72x	2.8%	344B
NOVARTIS AG	20.06x	5.27x	12.98x	3.02%	272B
ASTRAZENECA PLC	20.57x	4.22x	12.06x	2.1%	246B
AMGEN INC.	26.34x	6.83x	12.21x	2.43%	224B
GILEAD SCIENCES, INC.	-45.84x	6.75x	26.31x	2.18%	187B
Average	27.12x	6.72x	17.88x	2.22%	422.63B
Weighted average by Cap.	32.41x	7.85x	19.34x	1.9%